Importance of early tumour exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone for advanced prostatic cancer. Issue 6506 (16th November 1985) - Waxman, J; Man, A; Hendry, W F; Whitfield, H N; Besser, G M; Tiptaft, R C; Paris, A M; Oliver, R T